{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:21:08Z","timestamp":1793128868781,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":107,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mitochondrial dysfunction and oxidative stress are central to the pathogenesis of Parkinson\u2019s disease (PD), particularly affecting substantia nigra pars compacta (SNc) dopamine (DA) neurons. Here, we investigate how the R1441G mutation in leucine-rich repeat kinase 2 (LRRK2), a key genetic contributor to familial and sporadic PD, impacts mitochondrial function in midbrain DA neurons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We employed a BAC transgenic mouse model overexpressing human LRRK2\u2013R1441G (BAC-hR1441G) and crossed it with TH-mito-roGFP mice to enable mitochondria-targeted redox imaging specifically in DA neurons. Acute midbrain slices from 3-, 6-, and 12-month-old mice were imaged using two-photon microscopy to assess mitochondrial oxidative stress. In parallel, mitochondrial respiratory function, membrane potential flickering events, and expression of uncoupling proteins (UCP4\/UCP5) were analyzed. Spatial transcriptomic profiling was performed using the GeoMx\u00ae Digital Spatial Profiler to uncover associated molecular alterations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We observed a progressive increase in mitochondrial oxidative stress in SNc DA neurons of BAC-hR1441G mice at 3, 6, and 12\u2009months of age. This was accompanied by reduced respiratory complex activity, attenuated mitochondrial membrane potential flickering, and diminished expression of UCP4 and UCP5. Spatial transcriptomic analysis revealed dysregulation of genes linked to mitochondrial uncoupling, calcium signaling, and redox regulation in BAC-hR1441G SNc DA neurons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings reveal an age-dependent progression of mitochondrial dysfunction in BAC-hR1441G SNc DA neurons. Dysregulation of calcium channels and uncoupling proteins emerges as a key mechanism contributing to bioenergetic failure, suggesting potential therapeutic targets to mitigate PD progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-026-00969-7","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:45:40Z","timestamp":1783388740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The human LRRK2-R1441G mutation drives age-dependent oxidative stress and mitochondrial dysfunction in dopaminergic neurons"],"prefix":"10.1186","volume":"21","author":[{"given":"Yuanxin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianteng","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiquan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenbo","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"19","key":"969_CR1","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/FEBS.14607","volume":"285","author":"DJ Surmeier","year":"2018","unstructured":"Surmeier DJ. Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J. 2018;285(19):3657\u201368. https:\/\/doi.org\/10.1111\/FEBS.14607.","journal-title":"The FEBS J"},{"issue":"5","key":"969_CR2","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","volume":"322","author":"HA Lashuel","year":"2002","unstructured":"Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, et al. \u03b1-synuclein, especially the Parkinson\u2019s disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol. 2002;322(5):1089\u2013102. https:\/\/doi.org\/10.1016\/S0022-2836(02)00735-0.","journal-title":"J Mol Biol"},{"issue":"6","key":"969_CR3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S. Parkinson\u2019s disease. Neuron. 2003;39(6):889\u2013909. https:\/\/doi.org\/10.1016\/S0896-6273(03)00568-3.","journal-title":"Neuron"},{"issue":"5","key":"969_CR4","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/BRAIN\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ. Ageing and parkinson\u2019s disease: substantia nigra regional selectivity. Brain. 1991;114(5):2283\u2013301. https:\/\/doi.org\/10.1093\/BRAIN\/114.5.2283.","journal-title":"Brain"},{"issue":"7324","key":"969_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/NATURE09536","volume":"468","author":"JN Guzman","year":"2010","unstructured":"Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT, et al. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature. 2010;468(7324):696\u2013700. https:\/\/doi.org\/10.1038\/NATURE09536.","journal-title":"Nature"},{"issue":"4","key":"969_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44(4):601\u201307. https:\/\/doi.org\/10.1016\/j.neuron.2004.11.005.","journal-title":"Neuron"},{"issue":"46","key":"969_CR7","doi-asserted-by":"publisher","first-page":"16842","DOI":"10.1073\/PNAS.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, et al. Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA. 2005;102(46):16842\u201347. https:\/\/doi.org\/10.1073\/PNAS.0507360102.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"969_CR8","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1042\/BST20180462","volume":"47","author":"JH Kluss","year":"2019","unstructured":"Kluss JH, Mamais A, Cookson MR. LRRK2 links genetic and sporadic Parkinson\u2019s disease. Biochem Soc Trans. 2019;47(2):651\u201361. https:\/\/doi.org\/10.1042\/BST20180462.","journal-title":"Biochem Soc Trans"},{"issue":"7","key":"969_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O\u2019Sullivan SS, Bonifati V, Durr A, Bressman S, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol. 2008;7(7):583\u201390. https:\/\/doi.org\/10.1016\/S1474-4422(08)70117-0.","journal-title":"The Lancet Neurol"},{"issue":"12","key":"969_CR10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/NRN2935","volume":"11","author":"MR Cookson","year":"2010","unstructured":"Cookson MR. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson\u2019s disease. Nat Rev Neurosci. 2010;11(12):791\u2013797. https:\/\/doi.org\/10.1038\/NRN2935.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"969_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/J.AJPATH.2012.10.027","volume":"182","author":"SJ Cherra","year":"2013","unstructured":"Cherra SJ, Steer E, Gusdon AM, Kiselyov K, Chu CT. Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons. Am J Pathol. 2013;182(2):474\u201384. https:\/\/doi.org\/10.1016\/J.AJPATH.2012.10.027.","journal-title":"Am J Pathol"},{"issue":"9","key":"969_CR12","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/HMG\/DDS003","volume":"21","author":"X Wang","year":"2012","unstructured":"Wang X, Yan MH, Fujioka H, Liu J, Wilson-Delfosse A, Chen SG, et al. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet. 2012;21(9):1931\u201344. https:\/\/doi.org\/10.1093\/HMG\/DDS003.","journal-title":"Hum Mol Genet"},{"key":"969_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/J.BRAINRES.2018.06.010","volume":"1702","author":"A Singh","year":"2019","unstructured":"Singh A, Zhi L, Zhang H. LRRK2 and mitochondria: recent advances and current views. Brain Res. 2019;1702:96\u2013104. https:\/\/doi.org\/10.1016\/J.BRAINRES.2018.06.010.","journal-title":"Brain Res"},{"issue":"2","key":"969_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cell.2014.01.064","volume":"157","author":"I Martin","year":"2014","unstructured":"Martin I, Kim JW, Lee BD, Kang HC, Xu JC, Jia H, et al. Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in parkinson\u2019s disease. Cell. 2014;157(2):472\u201385. https:\/\/doi.org\/10.1016\/j.cell.2014.01.064.","journal-title":"Cell"},{"issue":"6","key":"969_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1523\/ENEURO.0310-21.2021","volume":"8","author":"JW Kim","year":"2021","unstructured":"Kim JW, Yin X, Martin I, Xiong Y, Eacker SM, Ingolia NT, et al. Dysregulated mRNA Translation in the G2019S LRRK2 and LRRK2 knock-out Mouse brains. eNeuro. 2021;8(6):8. https:\/\/doi.org\/10.1523\/ENEURO.0310-21.2021.","journal-title":"eNeuro"},{"key":"969_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/J.NBD.2013.10.013","volume":"62","author":"LH Sanders","year":"2014","unstructured":"Sanders LH, Lagani\u00e8re J, Cooper O, Mak SK, Vu BJ, Huang YA, et al. LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson\u2019s disease patients: reversal by gene correction. Neurobiol Disease. 2014;62:381\u201386. https:\/\/doi.org\/10.1016\/J.NBD.2013.10.013.","journal-title":"Neurobiol Disease"},{"issue":"451","key":"969_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aar5429","volume":"10","author":"R Di Maio","year":"2018","unstructured":"Di Maio R, Hoffman EK, Rocha EM, Keeney MT, Sanders LH, De Miranda BR, et al. LRRK2 activation in idiopathic Parkinson\u2019s disease. Sci Transl Med. 2018;10(451):1\u201313. https:\/\/doi.org\/10.1126\/scitranslmed.aar5429.","journal-title":"Sci Transl Med"},{"issue":"4","key":"969_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/J.STEM.2020.08.002","volume":"27","author":"JW Kim","year":"2020","unstructured":"Kim JW, Yin X, Jhaldiyal A, Khan MR, Martin I, Xie Z, et al. Defects in mRNA Translation in LRRK2-mutant hiPSC-Derived dopaminergic neurons lead to dysregulated calcium homeostasis. Cell STEM Cell. 2020;27(4):633\u201345.e7. https:\/\/doi.org\/10.1016\/J.STEM.2020.08.002.","journal-title":"Cell STEM Cell"},{"issue":"2","key":"969_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/J.BBADIS.2005.10.007","volume":"1762","author":"SS Sheu","year":"2006","unstructured":"Sheu SS, Nauduri D, Anders MW. Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim Et Biophys Acta (BBA) - Mol Basis Disease. 2006;1762(2):256\u201365. https:\/\/doi.org\/10.1016\/J.BBADIS.2005.10.007.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Basis Disease"},{"issue":"11","key":"969_CR20","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/J.BBABIO.2009.06.004","volume":"1787","author":"G Csord\u00e1s","year":"2009","unstructured":"Csord\u00e1s G, Hajn\u00f3czky G. SR\/ER\u2013mitochondrial local communication: calcium and ROS. Biochim et Biophys Acta (BBA) - Bioenerg. 2009;1787(11):1352\u201362. https:\/\/doi.org\/10.1016\/J.BBABIO.2009.06.004.","journal-title":"Biochim et Biophys Acta (BBA) - Bioenerg"},{"issue":"5","key":"969_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/J.TINS.2009.01.006","volume":"32","author":"CS Chan","year":"2009","unstructured":"Chan CS, Gertler TS, Surmeier DJ. Calcium homeostasis, selective vulnerability and Parkinson\u2019s disease. Trends Neurosciences. 2009;32(5):249\u201356. https:\/\/doi.org\/10.1016\/J.TINS.2009.01.006.","journal-title":"Trends Neurosciences"},{"key":"969_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.neuroscience.2011.08.045","volume":"198","author":"DJ Surmeier","year":"2011","unstructured":"Surmeier DJ, Guzman JN, Sanchez-Padilla J, Schumacker PT. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson\u2019s disease. Neuroscience. 2011;198:221\u201331. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.08.045.","journal-title":"Neuroscience"},{"key":"969_CR23","doi-asserted-by":"publisher","unstructured":"Guzman JN, Ilijic E, Yang B, Sanchez-Padilla J, Wokosin D, Galtieri D, et al. Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress. J Clin Invest. 2018;128(6):2266\u201380. https:\/\/doi.org\/10.1172\/JCI95898.","DOI":"10.1172\/JCI95898"},{"issue":"7","key":"969_CR24","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nn.2349","volume":"12","author":"Y Li","year":"2009","unstructured":"Li Y, Liu W, Oo TF, Wang L, Tang Y, Jackson-Lewis V, et al. Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson\u2019s disease. Nat Neurosci. 2009;12(7):826-828. https:\/\/doi.org\/10.1038\/nn.2349.","journal-title":"Nat Neurosci"},{"issue":"9\u201310","key":"969_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1089\/ars.2005.7.1173","volume":"7","author":"JS Kim-Han","year":"2005","unstructured":"Kim-Han JS, Dugan LL. Mitochondrial uncoupling proteins in the central nervous System. Antioxid Redox Signal. 2005;7(9\u201310):1173\u201381. https:\/\/doi.org\/10.1089\/ARS.2005.7.1173. https:\/\/home.liebertpub.com\/ars.","journal-title":"Antioxid Redox Signal"},{"key":"969_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.NEUROBIOLAGING.2018.10.025","volume":"75","author":"L Zhi","year":"2019","unstructured":"Zhi L, Qin Q, Muqeem T, Seifert EL, Liu W, Zheng S, et al. Loss of PINK1 causes age-dependent decrease of dopamine release and mitochondrial dysfunction. Neurobiol Aging. 2019;75:1\u201310. https:\/\/doi.org\/10.1016\/J.NEUROBIOLAGING.2018.10.025.","journal-title":"Neurobiol Aging"},{"issue":"49","key":"969_CR27","doi-asserted-by":"publisher","first-page":"16213","DOI":"10.1523\/JNEUROSCI.2246-15.2015","volume":"35","author":"E Santini","year":"2015","unstructured":"Santini E, Turner KL, Ramaraj AB, Murphy MP, Klann E, Kaphzan H. Mitochondrial superoxide contributes to hippocampal synaptic dysfunction and memory deficits in angelman syndrome model mice. J Neurosci. 2015;35(49):16213\u201320. https:\/\/doi.org\/10.1523\/JNEUROSCI.2246-15.2015.","journal-title":"J Neurosci"},{"issue":"2","key":"969_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/cns.12660","volume":"23","author":"Q Qin","year":"2017","unstructured":"Qin Q, Zhi LT, Li XT, Yue ZY, Li GZ, Zhang H. Effects of LRRK2 inhibitors on nigrostriatal dopaminergic neurotransmission. CNS Neurosci Ther. 2017;23(2):162\u201373. https:\/\/doi.org\/10.1111\/cns.12660.","journal-title":"CNS Neurosci Ther"},{"key":"969_CR29","doi-asserted-by":"publisher","unstructured":"Moore DJ, West AB, Dawson VL, Dawson TM. Molecular pathophysiology of parkinson\u2019s disease. Annu Rev Neurosci. 2005;28:57\u201387. https:\/\/doi.org\/10.1146\/annurev.neuro.28.061604.135718.","DOI":"10.1146\/annurev.neuro.28.061604.135718"},{"issue":"1","key":"969_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-150769","volume":"6","author":"P Tagliaferro","year":"2016","unstructured":"Tagliaferro P, Burke RE. Retrograde axonal degeneration in parkinson disease. J Parkinson\u2019s Disease. 2016;6(1):1-15. https:\/\/doi.org\/10.3233\/JPD-150769.","journal-title":"J Parkinson\u2019s Disease"},{"key":"969_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/J.EXPNEUROL.2012.01.011","volume":"246","author":"RE Burke","year":"2013","unstructured":"Burke RE, O\u2019Malley K. Axon degeneration in Parkinson\u2019s disease. Exp Neurol. 2013;246:72\u201383. https:\/\/doi.org\/10.1016\/J.EXPNEUROL.2012.01.011.","journal-title":"Exp Neurol"},{"issue":"2","key":"969_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5607\/EN.2015.24.2.103","volume":"24","author":"HE Moon","year":"2015","unstructured":"Moon HE, Paek SH. Mitochondrial dysfunction in Parkinson\u2019s disease. Exp Neurobiol. 2015;24(2):103\u2013116. https:\/\/doi.org\/10.5607\/EN.2015.24.2.103.","journal-title":"Exp Neurobiol"},{"key":"969_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.nbd.2015.07.009","volume":"82","author":"P Tagliaferro","year":"2015","unstructured":"Tagliaferro P, Kareva T, Oo TF, Yarygina O, Kholodilov N, Burke RE. An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson's disease. Neurobiol Disease. 2015;82:359\u201371. https:\/\/doi.org\/10.1016\/j.nbd.2015.07.009.","journal-title":"Neurobiol Disease"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00969-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00969-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00969-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:58:07Z","timestamp":1792634287000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00969-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["969"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00969-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8177400\/v1","asserted-by":"object"}]},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"69"}}